Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 330

Similar articles for PubMed (Select 9229726)

1.

[Yeast infections: causative agents and their antifungal resistance in hospitalized pediatric patients and HIV-positive adults].

Rodero L, Boutureira M, Demkura H, Burkett A, Fernández C, Losso M, Jáuregui Rueda H, Monticelli A, Vitale R, Canteros C, Hochenfellner F, Vivot W, Davel G.

Rev Argent Microbiol. 1997 Jan-Mar;29(1):7-15. Spanish.

PMID:
9229726
2.

Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.

Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.

AIDS. 1994 Jul;8(7):945-50.

PMID:
7946104
3.

Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.

Tumbarello M, Caldarola G, Tacconelli E, Morace G, Posteraro B, Cauda R, Ortona L.

J Antimicrob Chemother. 1996 Oct;38(4):691-9.

4.

A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.

Still JM Jr, Law EJ, Belcher KE, Spencer SA.

Burns. 1995 May;21(3):167-70.

PMID:
7794495
5.
6.

Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.

Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, Lopez-Ribot JL, Gaitán-Cepeda LA, Quindós G.

Rev Iberoam Micol. 2005 Jun;22(2):83-92.

7.

Oral Candida isolates among HIV-infected subjects in Nigeria.

Nweze EI, Ogbonnaya UL.

J Microbiol Immunol Infect. 2011 Jun;44(3):172-7. doi: 10.1016/j.jmii.2011.01.028. Epub 2011 Jan 20.

PMID:
21524610
8.

Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.

Samaranayake YH, Samaranayake LP, Tsang PC, Wong KH, Yeung KW.

J Oral Pathol Med. 2001 Jul;30(6):336-46.

PMID:
11459319
9.
12.

In vitro susceptibility of 137 Candida sp. isolates from HIV positive patients to several antifungal drugs.

Magaldi S, Mata S, Hartung C, Verde G, Deibis L, Roldán Y, Marcano C.

Mycopathologia. 2001;149(2):63-8.

PMID:
11265163
13.

[Antifungal susceptibility of emerging yeast pathogens].

García-Martos P, Domínguez I, Marín P, García-Agudo R, Aoufi S, Mira J.

Enferm Infecc Microbiol Clin. 2001 Jun-Jul;19(6):249-56. Spanish.

PMID:
11440661
14.

Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.

Nadagir SD, Chunchanur SK, Halesh LH, Yasmeen K, Chandrasekhar MR, Patil BS.

Southeast Asian J Trop Med Public Health. 2008 May;39(3):492-5.

PMID:
18564689
16.

Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.

Barchiesi F, Arzeni D, Del Prete MS, Sinicco A, Falconi Di Francesco L, Pasticci MB, Lamura L, Nuzzo MM, Burzacchini F, Coppola S, Chiodo F, Scalise G.

J Antimicrob Chemother. 1998 May;41(5):541-8. Erratum in: J Antimicrob Chemother 1998 Sep;42(3):413.

17.

Oral colonization by yeasts in HIV-positive patients in Brazil.

Junqueira JC, Vilela SF, Rossoni RD, Barbosa JO, Costa AC, Rasteiro VM, Suleiman JM, Jorge AO.

Rev Inst Med Trop Sao Paulo. 2012 Jan-Feb;54(1):17-24.

18.
19.

Multicenter Brazilian study of oral Candida species isolated from AIDS patients.

Sant'Ana Pde L, Milan EP, Martinez R, Queiroz-Telles F, Ferreira MS, Alcântara AP, Carvalho MT, Colombo AL.

Mem Inst Oswaldo Cruz. 2002 Mar;97(2):253-7.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk